NGS platform to the Section for Molecular Pathology at the Department of Pathology, St Olav’s Hospital.

Hange

Eelteade
12.06.2018 10:47 (GMT+03:00)

Hankija

Sykehusinnkjøp HF Sykehusinnkjøp HF
Per Stavnesli Per Stavnesli
Postboks 40
9811 Vadsø
Norra
916879067

Eesmärk

Sykehusinnkjøp HF 916879067 Postboks 40 Vadsø 9811 Per Stavnesli per.stavnesli@sykehusinnkjop.no https://permalink.mercell.com/86860638.aspx http://www.sykehusinnkjop.no/ NGS platform to the Section for Molecular Pathology at the Department of Pathology, St Olav’s Hospital. 2018/783 St. Olav’s Hospital shall purchase an NGS platform to the Section for Molecular Pathology at the Department of Pathology, St Olav’s Hospital. . 900000.00 Trondheim. To conclude, the department needs an NGS platform that is compact, integrated and automated with bio-informatics analysis. At the same time, the NGS platform must be sensitive, effective, flexible and scalable. Refer to the attachment for argumentation before the conclusion and i.a. references. The contract will be signed at the earliest: 18.6.2018. Under the threshold value — See the attachment. 2018/783 NGS platform to the Section for Molecular Pathology at the Department of Pathology, St Olav’s Hospital. 2018-06-08 Thermo Fisher Scientific 986400990 Postboks 114 Smedstad Oslo 0309 900000.00 KOFA Bergen 2018-06-11

See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:251991-2018:TEXT:EN:HTML

Mercell Estonia OÜ

Mercelli gruppi kuuluv Euroopa juhtiv e-hanke keskkond vahendab infot ostjate ja tarnijate vahel.

Kontakt

Mercell Eesti kasutajatugi

+372 683 6785
Mercell Estonia OÜ | Põhja puiestee 21C, 10143 Tallinn, Eesti